Session Information
Free - CMES03 - Individualizing Diabetes Treatment for Improved Glycemic Control and Management of Comorbidities
Click here to go to the previous page
Introduction & Case Vignettes
Program Code:
CMES03-1
Date:
Sunday, June 5, 2011
Time:
7:00 PM to 7:15 PM
EST
Location:
Renaissance, Pacific Ballroom DEFGH
SPEAKER
:
David D'Alessio, MD, Univ of Cincinnati
Disclosure: Consultant, Amylin Pharmaceuticals, Merck & Co., Novo Nordisk, Takeda Pharmaceuticals; Research grant recipient, Ethicon Endo-Surgery, MannKind, sanofi-aventis U.S.; Speaker, Merck & Co.
Disclosure: Consultant, Amylin Pharmaceuticals, Merck & Co., Novo Nordisk, Takeda Pharmaceuticals; Research grant recipient, Ethicon Endo-Surgery, MannKind, sanofi-aventis U.S.; Speaker, Merck & Co.
Audio Synchronized to PowerPoint
